Business & Finance

Enpath Medical reports 22% increase in third quarter revenues

Published in Medical Patent Law Weekly, November 22nd, 2006

Enpath Medical, Inc. (NPTH), a developer and manufacturer of proprietary products for blue-chip medical device companies operating worldwide, reported improved third quarter results.

Third quarter financial highlights included:

- A 22% increase in revenues to $9.3 million compared with $7.7 million for the same quarter in 2005.

- Net income of $371,000 or $.06 per diluted share for the third quarter, compared with net income of $237,000 or $.04 per diluted share for the same quarter of 2005. Net income in the current quarter included tax benefits recognized of approximately $210,000.

- A 41% increase in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly

Source: Medical Patent Law Weekly (2006-11-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry